000 01501 a2200481 4500
005 20250513151948.0
264 0 _c19981022
008 199810s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.42.9.2391
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWalsh, T J
245 0 0 _aSafety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cSep 1998
300 _a2391-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAmphotericin B
_xadministration & dosage
650 0 4 _aAntifungal Agents
_xadministration & dosage
650 0 4 _aDrug Carriers
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLiposomes
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeutropenia
_xdrug therapy
700 1 _aYeldandi, V
700 1 _aMcEvoy, M
700 1 _aGonzalez, C
700 1 _aChanock, S
700 1 _aFreifeld, A
700 1 _aSeibel, N I
700 1 _aWhitcomb, P O
700 1 _aJarosinski, P
700 1 _aBoswell, G
700 1 _aBekersky, I
700 1 _aAlak, A
700 1 _aBuell, D
700 1 _aBarret, J
700 1 _aWilson, W
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 42
_gno. 9
_gp. 2391-8
856 4 0 _uhttps://doi.org/10.1128/AAC.42.9.2391
_zAvailable from publisher's website
999 _c9701620
_d9701620